Ledger.Open graph →
SEC Form D · filed December 5, 2016

KPI Therapeutics, Inc

Offering
$3.0M
Sold
$18K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Shawn E. Iadonato · Seattle, WADirectorCraig E. Philips · Seattle, WAExecCharles L. Magness · Seattle, WAExec · DirectorDon E. Merlino · Seattle, WADirectorJames G. W. E. Reed · Seattle, WADirectorRay E. Bartoszek · Seattle, WADirectorPaul E. Sylvester · Seattle, WADirectorSteven E. Mitchel · Seattle, WADirectorThomas E. Hornish · Seattle, WAExecShawn E. Iadonato · Seattle, WADirectorJames G. W. E. Reed · Seattle, WADirectorRay E. Bartoszek · Seattle, WADirectorCraig E. Philips · Seattle, WAExecPaul E. Sylvester · Seattle, WADirectorCharles L. Magness · Seattle, WAExec · DirectorSteven E. Mitchel · Seattle, WADirectorDon E. Merlino · Seattle, WADirectorThomas E. Hornish · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗